Related Experiment Video
Updated: Aug 15, 2026

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
Published on: March 7, 2025
The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis
Toshiaki Monkawa1, Jeffrey Pippin, Yoshikage Yo
1Division of Nephrology, University of Washington, Seattle, Washington, USA.
Background:
Mesangial cell (MC) proliferation underlies increased matrix accumulation in glomerulonephritis (GN), and the resolution of MC proliferation occurs largely through apoptosis. Proliferation and apoptosis are controlled by specific cell cycle proteins, where cyclin-dependent kinase (CDK) inhibitors such as p21 bind target cyclin-CDK complexes. However, the role of p21 in acute mesangial proliferative GN is not known. This study was conducted to test the hypothesis that p21 regulates MC proliferation and apoptosis in anti-MC serum-induced GN.
Methods:
Age and sex matched wild-type (p21+/+) and p21-deficient (p21-/-) mice were injected with sheep anti-MC serum. Renal function (BUN, urinary albumin excretion), histology, DNA synthesis (BrdU. Ki-67) and apoptosis (TUNEL) were quantified at day 6 and day 12 (n = 6-8/time point).
Results:
In p21+/+ mice, anti-MC-serum induced mild MC proliferative GN, and glomerular p21 expression was increased. Renal function was worse in nephric p21-/- mice. PAS and silver staining revealed that p21-/- mice had typical features of MC proliferative GN with focal segmental tuft necrosis, focal mesangiolysis and focal mesangial hypercellularity. Occasional features of podocyte injury (swelling, vacuolization) were noted. Double immunostaining confirmed increased mesangial cell DNA synthesis in nephritic p21-/- mice at day 6. In contrast, there was no difference in glomerular apoptosis in nephritic p21+/+ and p21-/- mice at each time point. Glomerular lesions were accompanied by severe glomerular and tubulointerstitial fibrosis in p21-/- mice.
Conclusions:
This data shows that the CDK-inhibitor p21 regulates the MC proliferative response to immune-mediated injury. In contrast, p21 does not alter the apoptotic response, resulting in a delayed resolution in nephritic p21-/- mice.
Insights
The cyclin-dependent kinase inhibitor p21 regulates mesangial cell proliferation in glomerulonephritis but does not affect apoptosis, leading to delayed healing in deficient mice.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Mesangial cell (MC) proliferation and apoptosis are key to glomerulonephritis (GN) progression and resolution.
- Cyclin-dependent kinase (CDK) inhibitors, like p21, regulate cell cycle proteins involved in proliferation and apoptosis.
- The specific role of p21 in acute mesangial proliferative GN remains unclear.
Purpose of the Study:
- To investigate the role of p21 in regulating MC proliferation and apoptosis during anti-MC serum-induced GN.
- To test the hypothesis that p21 controls MC proliferation and apoptosis in this GN model.
Main Methods:
- Wild-type (p21+/+) and p21-deficient (p21-/-) mice were subjected to anti-MC serum induction.
- Renal function, histology, DNA synthesis (BrdU, Ki-67), and apoptosis (TUNEL) were assessed at days 6 and 12.
Main Results:
- p21 deficiency worsened renal function and exacerbated MC proliferative GN features, including necrosis and hypercellularity.
- Mesangial cell DNA synthesis was increased in p21-/- mice, while apoptosis remained unchanged.
- p21-/- mice exhibited severe glomerular and tubulointerstitial fibrosis.
Conclusions:
- The CDK-inhibitor p21 is a key regulator of the mesangial cell proliferative response to immune-mediated kidney injury.
- p21 does not influence the apoptotic response, contributing to delayed resolution of GN in its absence.
- These findings highlight p21's critical role in managing the proliferative aspect of glomerulonephritis.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
